BWIV-UN (BWIV-UN) - Net Assets
Based on the latest financial reports, BWIV-UN (BWIV-UN) has net assets worth $- USD as of . Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
BWIV-UN - Net Assets Trend (None–None)
This chart illustrates how BWIV-UN's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BWIV-UN (None–None)
The table below shows the annual net assets of BWIV-UN from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to BWIV-UN's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
BWIV-UN Competitors by Market Cap
The table below lists competitors of BWIV-UN ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
European Energy Metals Corp.
OTCQB:EUEMF
|
$992.69 |
|
Idea Acquisition Corp. Units
NASDAQ:IACOU
|
$993.00 |
|
Cambridge Acquisition Corp. Unit
NASDAQ:CAQUU
|
$993.00 |
|
FL ENTERTAINMENT N.V. EO1
F:H98
|
$993.74 |
|
Bullpen Parlay Acquisition Co Unit
NASDAQ:BPACU
|
$991.50 |
|
Praetorian Acquisition Corp. Units
NASDAQ:PTORU
|
$991.30 |
|
PELIU
NASDAQ:PELIU
|
$990.00 |
|
Universal Global Hub Inc
PINK:UGHB
|
$989.05 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BWIV-UN's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares BWIV-UN's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently BWIV-UN utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares BWIV-UN's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $103,216,012
- Average return on equity (ROE) among peers: 4.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BWIV-UN (BWIV-UN) | $- | N/A | N/A | $992.00 |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $229.73 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $265.09 Million |
| Ares Acquisition Corporation II (AACT) | $502.67 Million | 0.00% | 0.05x | $587.05 Million |
| AA Mission Acquisition Corp. (AAM) | $534.70 Million | 21.49% | 3.04x | $409.92K |
| Global Acquisitions Corporation (AASP) | $-5.69 Million | 0.00% | 0.00x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $-341.70K | 0.00% | 0.00x | $461.96K |
| Averin Capital Acquisition Corp. Units (ACAAU) | $-48.38K | 0.00% | 0.00x | $1.00K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $23.21K | -7.73% | 14.57x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-275.23K | 0.00% | 0.00x | $14.44K |
| ACRO Biomedical Co Ltd (ACBM) | $1.24 Million | 33.78% | 0.19x | $30.04K |
About BWIV-UN
Blue Water Acquisition Corp. IV does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology, healthcare, and technology industries. The company was incorporated in 2025 and is based in Greenwich, Connecticut.